C07C29/86

PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES
20220363619 · 2022-11-17 ·

The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

Dynamic interface system and its application in supercritical fluid extraction and chromatography

The present invention provides a dynamic interface system between an extraction device and a chromatographic purification device for separating and purifying substance(s) from a mixture or matrix. One embodiment is the Supercritical Fluid Interface (“SFI”) between Supercritical Fluid Extraction (“SFE”), and Supercritical Fluid Chromatography (“SFC”). The SFI is capable of interfacing; gas, subcritical and supercritical fluid extraction methods and pair with gas, subcritical and supercritical fluid chromatography technologies that operate within the pressure and temperature parameters of the SFI. The SFI can operate up to 200 degrees celsius and 5000 psi. This interface technology allows for an inline oil extraction and chromatographic separation, the SFI can pair extraction and chromatography with the same solvent in different mobile phases, whereas the extraction can be performed using CO.sub.2 as a solvent in sub-critical phase and the SFI can receive the subcritical solution and then increase pressure and/or temperature to achieve supercritical state as required for injection into supercritical fluid chromatography technologies. The SFI coupling between SFE and SFC can to extract and refine cannabinoids from the cannabis industrious, hemp, plant and can also be applied to improve efficiency in an industry that extracts and refines oils, through chromatography, from organic materials using a gas, or sub/supercritical fluid as a solvent and mobile phase.

Dynamic interface system and its application in supercritical fluid extraction and chromatography

The present invention provides a dynamic interface system between an extraction device and a chromatographic purification device for separating and purifying substance(s) from a mixture or matrix. One embodiment is the Supercritical Fluid Interface (“SFI”) between Supercritical Fluid Extraction (“SFE”), and Supercritical Fluid Chromatography (“SFC”). The SFI is capable of interfacing; gas, subcritical and supercritical fluid extraction methods and pair with gas, subcritical and supercritical fluid chromatography technologies that operate within the pressure and temperature parameters of the SFI. The SFI can operate up to 200 degrees celsius and 5000 psi. This interface technology allows for an inline oil extraction and chromatographic separation, the SFI can pair extraction and chromatography with the same solvent in different mobile phases, whereas the extraction can be performed using CO.sub.2 as a solvent in sub-critical phase and the SFI can receive the subcritical solution and then increase pressure and/or temperature to achieve supercritical state as required for injection into supercritical fluid chromatography technologies. The SFI coupling between SFE and SFC can to extract and refine cannabinoids from the cannabis industrious, hemp, plant and can also be applied to improve efficiency in an industry that extracts and refines oils, through chromatography, from organic materials using a gas, or sub/supercritical fluid as a solvent and mobile phase.

PURIFICATION PROCESSING APPARATUS, SUBSTRATE PROCESSING SYSTEM, AND PROCESSING METHOD

A purification processing apparatus for supplying purified isopropyl alcohol to a substrate processing apparatus. The purification processing apparatus includes: a processing chamber in which unpurified isopropyl alcohol and ionic liquid are mixed, and the isopropyl alcohol and the ionic liquid are separated to purify the isopropyl alcohol; an unpurified solvent supply port configured to supply the unpurified isopropyl alcohol to the processing chamber; an ionic liquid supply port configured to supply the ionic liquid to the processing chamber; and a purified solvent outlet configured to supply the purified isopropyl alcohol from the processing chamber to the substrate processing apparatus.

PURIFICATION PROCESSING APPARATUS, SUBSTRATE PROCESSING SYSTEM, AND PROCESSING METHOD

A purification processing apparatus for supplying purified isopropyl alcohol to a substrate processing apparatus. The purification processing apparatus includes: a processing chamber in which unpurified isopropyl alcohol and ionic liquid are mixed, and the isopropyl alcohol and the ionic liquid are separated to purify the isopropyl alcohol; an unpurified solvent supply port configured to supply the unpurified isopropyl alcohol to the processing chamber; an ionic liquid supply port configured to supply the ionic liquid to the processing chamber; and a purified solvent outlet configured to supply the purified isopropyl alcohol from the processing chamber to the substrate processing apparatus.

PURIFICATION PROCESSING APPARATUS, SUBSTRATE PROCESSING SYSTEM, AND PROCESSING METHOD

A purification processing apparatus for supplying purified isopropyl alcohol to a substrate processing apparatus. The purification processing apparatus includes: a processing chamber in which unpurified isopropyl alcohol and ionic liquid are mixed, and the isopropyl alcohol and the ionic liquid are separated to purify the isopropyl alcohol; an unpurified solvent supply port configured to supply the unpurified isopropyl alcohol to the processing chamber; an ionic liquid supply port configured to supply the ionic liquid to the processing chamber; and a purified solvent outlet configured to supply the purified isopropyl alcohol from the processing chamber to the substrate processing apparatus.

Process to recover 3-methyl-but-3-en-1-ol

The presently claimed invention relates to a process for the recovery of 3-methyl-3-buten- -ol from a stream comprising (Z)-3-methylpent-2-ene-1,5-diol, (E)-3-methylpent-2-ene-,5-diol and 3-methylenepentane-1,5-diol by treating the stream with isobutene and water.

Process to recover 3-methyl-but-3-en-1-ol

The presently claimed invention relates to a process for the recovery of 3-methyl-3-buten- -ol from a stream comprising (Z)-3-methylpent-2-ene-1,5-diol, (E)-3-methylpent-2-ene-,5-diol and 3-methylenepentane-1,5-diol by treating the stream with isobutene and water.

METHODS FOR INCREASING HYDROFORMYLATION CATALYST PREFORMING RATES

Catalyst preforming rates during hydroformylation may decrease in the presence of carbonates. Carbonate mitigation methods may comprise treating a hydroformylation reaction product with an aqueous carboxylic acid under oxidizing conditions to form a deactivated catalyst aqueous solution having a pH of about 4 or less, reducing the hydroformylation reaction product to form a reduced reaction product, conveying a gas stream through the reduced reaction product to strip carbon dioxide therefrom, contacting caustic aqueous solution with the stripped reduced reaction product to form partially spent caustic aqueous solution, combining at least a portion of the partially spent caustic aqueous solution with the deactivated catalyst aqueous solution to form a combined aqueous mixture sufficiently acidic to decompose carbonate, and extracting a Group 9 transition metal carboxylate from the combined aqueous mixture into an organic phase.

METHODS FOR INCREASING HYDROFORMYLATION CATALYST PREFORMING RATES

Catalyst preforming rates during hydroformylation may decrease in the presence of carbonates. Carbonate mitigation methods may comprise treating a hydroformylation reaction product with an aqueous carboxylic acid under oxidizing conditions to form a deactivated catalyst aqueous solution having a pH of about 4 or less, reducing the hydroformylation reaction product to form a reduced reaction product, conveying a gas stream through the reduced reaction product to strip carbon dioxide therefrom, contacting caustic aqueous solution with the stripped reduced reaction product to form partially spent caustic aqueous solution, combining at least a portion of the partially spent caustic aqueous solution with the deactivated catalyst aqueous solution to form a combined aqueous mixture sufficiently acidic to decompose carbonate, and extracting a Group 9 transition metal carboxylate from the combined aqueous mixture into an organic phase.